52w high/low | ₹137.7 / ₹49.55 |
P/E ratio | 18.29 |
Dividend | 0.96 |
ROE | 9.73 |
ROCE | 11.36 |
Face value | 10 |
Book value | ₹66.39Cr |
Market capital | ₹198.06Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
Bal Pharma (BPL), a member of the Mcro Laboratories group, was incorporated as a private limited company in May '87. In Mar. '90, BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25. 18 lac following which, BPL commenced manufacturing formulations. BPL manufactures and markets pharmaceutical formulations -- paracetamol, aluminium hydroxide, povidone iodine, alprazolam, gliclazide, griseofulvin, lactobacillus, rifampicin, piroxicam amoxycillin, etc. The company promotes its products through the common sales force of the group but proposes to induct its own soon. It came out with a public issue in Feb. '95 for manufacture of bulk drugs and expansion of pharmaceutical formulations.